• search hit 4 of 12
Back to Result List

Importance of Pancreatic Enzyme Replacement Therapy after Surgery of Cancer of the Esophagus or the Esophagogastric Junction

  • After surgical treatment of cancer of the esophagus or the esophagogastric junction we observed steatorrhea, which is so far seldom reported. We analyzed all patients treated in our rehabilitation clinic between 2011 and 2014 and focused on the impact of surgery on digestion of fat. Reported steatorrhea was anamnestic, no pancreatic function test was made. Here we show the results from 51 patients. Twenty-three (45%) of the patients reported steatorrhea. Assuming decreased pancreatic function pancreatic enzyme replacement therapy (PERT) was started or modified during the rehabilitation stay (in the following called STEA(+)). These patients were compared with the patients without steatorrhea and without PERT (STEA(-)). Maximum weight loss between surgery and rehabilitation start was 18 kg in STEA(+) patient and 15.3 kg in STEA(-) patients. STEA(+) patients gained more weight under PERT during the rehabilitation phase (3 wk) than STEA(-) patients without PERT (+1.0 kg vs. -0.3 kg, P = 0.032). We report for the first time, that patientsAfter surgical treatment of cancer of the esophagus or the esophagogastric junction we observed steatorrhea, which is so far seldom reported. We analyzed all patients treated in our rehabilitation clinic between 2011 and 2014 and focused on the impact of surgery on digestion of fat. Reported steatorrhea was anamnestic, no pancreatic function test was made. Here we show the results from 51 patients. Twenty-three (45%) of the patients reported steatorrhea. Assuming decreased pancreatic function pancreatic enzyme replacement therapy (PERT) was started or modified during the rehabilitation stay (in the following called STEA(+)). These patients were compared with the patients without steatorrhea and without PERT (STEA(-)). Maximum weight loss between surgery and rehabilitation start was 18 kg in STEA(+) patient and 15.3 kg in STEA(-) patients. STEA(+) patients gained more weight under PERT during the rehabilitation phase (3 wk) than STEA(-) patients without PERT (+1.0 kg vs. -0.3 kg, P = 0.032). We report for the first time, that patients after cancer related esophageal surgery show anamnestic signs of exocrine pancreas insufficiency and need PERT to gain body weight.show moreshow less

Export metadata

Additional Services

Search Google Scholar Statistics
Metadaten
Author details:Thomas Kiefer, Dorothea Krahl, Kathrin Osthoff, Peter Thuss-PatienceGND, Jörg Bunse, Ulrich AdamORCiD, Marc H. Jansen, Rudolf Ott, Robert PfitzmannGND, Matthias Pross, Thomas KohlmannGND, Georg DaeschleinGND, Hermann Buhlert, Heinz VöllerORCiDGND, Carsten HirtORCiD
DOI:https://doi.org/10.1080/01635581.2017.1374419
ISSN:0163-5581
ISSN:1532-7914
Pubmed ID:https://pubmed.ncbi.nlm.nih.gov/28945459
Title of parent work (English):Nutrition and cancer : an international journal
Publisher:Routledge, Taylor & Francis Group
Place of publishing:Abingdon
Publication type:Article
Language:English
Date of first publication:2017/09/25
Publication year:2017
Release date:2022/03/31
Volume:70
Issue:1
Number of pages:4
First page:69
Last Page:72
Funding institution:Department of Medical Oncology of the Klinik am See, Rudersdorf, Berlin
Organizational units:Humanwissenschaftliche Fakultät / Strukturbereich Kognitionswissenschaften / Department Sport- und Gesundheitswissenschaften
DDC classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Peer review:Referiert
Accept ✔
This website uses technically necessary session cookies. By continuing to use the website, you agree to this. You can find our privacy policy here.